Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.

Journal of the National Cancer Institute. Monographs

Volumn , Issue 36, 2006, Pages 7-15

  Mariotto, Angela B ^a   Feuer, Eric J ^a   Harlan, Linda C ^a   Abrams, Jeffrey ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; ESTROGEN RECEPTOR; TAMOXIFEN;

ADJUVANT CHEMOTHERAPY; AGED; ARTICLE; BREAST TUMOR; CANCER REGISTRY; CANCER STAGING; FEMALE; HUMAN; MASS COMMUNICATION; META ANALYSIS; MIDDLE AGED; PREDICTION AND FORECASTING; STATISTICAL MODEL; STATISTICS; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES; UTILIZATION REVIEW;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DIFFUSION OF INNOVATION; FEMALE; HUMANS; META-ANALYSIS; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RECEPTORS, ESTROGEN; SEER PROGRAM; SURVIVAL RATE; TAMOXIFEN; TREATMENT OUTCOME; UNITED STATES;

EID: 39049180984     PISSN: 10526773     EISSN: None     Source Type: Journal    
DOI: 10.1093/jncimonographs/lgj003     Document Type: Article

References (0)